BB

Balusamy Bharathy Mohan

Active Director Managing Director DIN 10615683
DIN 10615683 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Balusamy Bharathy Mohan

Data last updated:

Balusamy Bharathy Mohan is a Managing Director at Meu Amor Life Sciences Private Limited (since 2024).

DIN 10615683
Primary Designation Managing Director
First Appointment 03 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director03 May 20242024Active

Board colleagues of Balusamy Bharathy Mohan

Directorship timeline

Open interactive timeline →
Meu Amor Life Sciences Private Limited
Premium access

Shareholding and investment profile for Balusamy Bharathy Mohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Balusamy Bharathy Mohan

Balusamy Bharathy Mohan currently holds 1 directorship: Meu Amor Life Sciences Private Limited (Managing Director, since 03 May 2024).

Balusamy Bharathy Mohan was first appointed on 03 May 2024 as Managing Director at Meu Amor Life Sciences Private Limited.

The current boards of Balusamy Bharathy Mohan's companies include Gurusamy Muralitharan (Meu Amor Life Sciences Private Limited), Kothandapani Elanchezhiyan (Meu Amor Life Sciences Private Limited), Murali (Meu Amor Life Sciences Private Limited), Ramesh Jeyaraja (Meu Amor Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available